PALATIN TECHNOLOGIES
We are a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Our programs are based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Our primary product in clinical development is bremelanotide for the treatment of female sexual dysfunction (FSD). In addition, we have drug candidates or development programs for obesity, erectile dysfunction, pulmonary diseases, cardiovascular diseases and inflammatory diseases. The following drug development programs are actively under development:
PALATIN TECHNOLOGIES
Industry:
Biotechnology Health Care Therapeutics
Founded:
1986-01-01
Address:
Cranbury, New Jersey, United States
Country:
United States
Website Url:
http://www.palatin.com
Total Employee:
11+
Status:
Active
Contact:
609-495-2200
Email Addresses:
[email protected]
Total Funding:
104.2 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Wordpress Plugins Global Site Tag
Current Employees Featured
Founder
Stock Details
Investors List
QVT Financial
QVT Financial investment in Post-IPO Equity - Palatin Technologies
Horizon Technology Finance
Horizon Technology Finance investment in Post-IPO Debt - Palatin Technologies
Alexandra Investment Management
Alexandra Investment Management investment in Post-IPO Equity - Palatin Technologies
Lurie Investment Fund
Lurie Investment Fund investment in Post-IPO Equity - Palatin Technologies
Albert Fried & Company
Albert Fried & Company investment in Post-IPO Equity - Palatin Technologies
Lombard Odier
Lombard Odier investment in Post-IPO Equity - Palatin Technologies
Perry Capital
Perry Capital investment in Post-IPO Equity - Palatin Technologies
NAI Elliott
NAI Elliott investment in Post-IPO Equity - Palatin Technologies
Deutsche Bank
Deutsche Bank investment in Post-IPO Equity - Palatin Technologies
Bank Clariden Leu
Bank Clariden Leu investment in Post-IPO Equity - Palatin Technologies
Official Site Inspections
http://www.palatin.com Semrush global rank: 4.17 M Semrush visits lastest month: 2.85 K
- Host name: palatin.tempurl.host
- IP address: 108.61.155.191
- Location: Paterson United States
- Latitude: 40.9138
- Longitude: -74.1896
- Metro Code: 501
- Timezone: America/New_York
- Postal: 07502
